I was buying back AVRX this week a little at a time, it has been so thin, and I was only buying a thousand shares a day. Your right when the shelf offering was released, I just stood aside and just waited. Secondaries hurt a stock short term, but in many cases longer term it can add support to the stock. Also, there was news from American Society of Hematology today, that should help next week.
News 
Market Data 
Discover 
